Safety and Efficacy Study of Sorafenib in Japanese Child-Pugh A and B Patients with Advanced Hepatocellular Carcinoma
Phase 2
- Conditions
- Advanced Hepatcellular Carcinoma
- Registration Number
- JPRN-UMIN000004215
- Lead Sponsor
- Chiba University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1)Second primary malignancy 2)Severe cardiac complication 3)Active infection 4)HIV infection 5)Encephalopacy 6)Gastro-esophazeal varices requiring preventive treatment 7)Uncontrolled massive ascitis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Time to Progression (TTP)
- Secondary Outcome Measures
Name Time Method